2018
J. M. Andrés et al.
LETTER
for 2 h and then warmed to r.t. and stirred for additional 13
h. The mixture was filtered, the solvent concentrated and the
residue was purified by flash chromatography (silca gel,
EtOAc–hexane 1:4, v/v).
J = 5.7 Hz, 1 H), 3.25–3.38 (m, 2 H), 3.76 (t, J = 8.7 Hz, 1
H), 4.08 (dd, J = 7.2, 8.4 Hz, 1 H), 4.33 (dd, J = 7.2, 8.7 Hz,
1 H), 7.24–7.40 (m, 5 H). 13C NMR (75 MHz, CD3Cl): d =
14.1, 22.6, 25.0, 26.9, 29.2, 29.9, 31.8, 35.0, 39.2, 63.3, 69.7,
71.0, 73.2, 108.2, 126.5 (2 C), 127.4, 128.7 (2 C), 141.7.
(14) (a) Ishihara, K.; Mori, A.; Yamamoto, H. Tetrahedron 1990,
46, 4595. (b) Alexakis, A.; Mangeney, P. Tetrahedron:
Asymmetry 1990, 1, 417. (c) Meyers, A. I.; Burgess, L. E. J.
Org. Chem. 1991, 56, 2294.
(15) Petersson-Fasth, H.; Riesinger, S. W.; Bäckvall, J. E. J. Org.
Chem. 1995, 60, 6091.
(16) Borch, R. F.; Evans, A. J.; Wade, J. J. J. Am. Chem. Soc.
1997, 99, 162.
(13) Spectroscopic data for compounds: 2a: [a]D25 +27.2 (c 0.7,
CHCl3). 1H NMR (300 MHz, CDCl3): d = 1.50 (s, 3 H),
1.60–1.73 (m, 1 H), 1.81–1.89 (m, 1 H), 1.96–2.09 (m, 2 H),
2.60 (br s, 1 H), 2.78 (dd, J = 5.0, 10.4 Hz, 1 H), 2.97–3.08
(m, 2 H), 3.98 (dd, J = 7.9, 9.9 Hz, 1 H), 4.13 (dd, J = 6.1,
7.9 Hz, 1 H), 4.62 (dd, J = 6.1, 9.9 Hz, 1 H), 7.25–7.5 (m, 5
H). 13C NMR (75 MHz, CD3Cl): d = 25.9, 27.3, 37.9, 59.7,
64.2, 64.3, 67.0, 106.5, 128.1, 128.5 (2 C), 128.9 (2 C),
135.4. Compound 2b: [a]D25 +7.3 (c 0.6, CHCl3). 1H NMR
(300 MHz, CDCl3): d = 0.88 (t, J = 6.5 Hz, 3 H), 1.20–1.57
(m, 10 H), 1.58–1.73 (m, 2 H), 1.74–1.91 (m, 2 H), 1.92–
2.15 (m, 2 H), 2.45 (br s, 1 H), 2.72 (dd, J = 4.7, 10.4 Hz, 1
H), 2.98 (dd, J = 3.7, 10.4 Hz, 1 H), 3.05–3.15 (m, 1 H), 4.0
(dd, J = 7.9, 10.0 Hz, 1 H), 4.11 (dd, J = 6.1, 7.8 Hz, 1 H),
(17) Lipshutz, B. In Organometallics in Synthesis; Schlosser, M.,
Ed.; John Wiley: New York, 1994, 305.
(18) Arseniyadis, S.; Huang, P. Q.; Piveteau, D.; Hüsson, H.-P.
Tetrahedron 1988, 44, 2457.
(19) Data for N-Boc Pyrrolidines: 5a: [a]D25 –9.9 (c 1.2, CHCl3).
4.60 (dd, J = 6.1, 10.0 Hz, 1 H), 7.25–7.52 (m, 5 H). 13
C
ent-5a: [a]D25 +9.95 (c 1.3, CHCl3). N-Boc derivatives of
25
NMR (75 MHz, CD3Cl): d = 14.1, 22.6, 25.2, 27.3, 29,3,
30.0, 31.8, 35.6, 39.2, 59.4, 63.8, 64.5, 66.6, 108.7, 128.2,
128.5 (2 C), 128.9 (2 C), 135.2. Compound 3a: [a]D25 –97.8
(c 0.7, CHCl3). 1H NMR (300 MHz, CDCl3): d = 1.48 (s, 3
H), 1.75–1.86 (m, 1 H), 1.92–2.11 (m, 3 H), 2.21–2.27 (m, 1
H), 3.10–3.15 (m, 1 H), 3.26–3.35 (m, 2 H), 3.83 (t, J = 8.6
Hz, 1 H), 4.05 (t, J = 7.6 Hz, 1 H), 4.34 (dd, J = 6.1, 8.6 Hz,
1 H), 7.23–7.40 (m, 5 H). 13C NMR (75 MHz, CD3Cl): d =
26.8, 27.2, 37.8, 63.2, 69.9, 70.8, 73.5, 105.8, 126.5 (2 C),
127.4, 128.7 (2 C), 141.6. Compound 3b: [a]D25 –70.6 (c 0.5,
CHCl3). 1H NMR (300 MHz, CDCl3) d = 0.90 (t, J = 6.5 Hz,
3 H), 1.29–1.61 (m, 11 H), 1.69–1.78 (m, 1 H), 1.81–1.93
(m, 1 H), 1.95–2.12 (m, 3 H), 2.27 (br s, 1 H), 3.13 (tq,
(2R,5R)-5-heptyl-2-hydroxymethyl pyrrolidine: [a]D
+4.1 (c 0.8, CHCl3). 1H NMR (300 MHz, CDCl3): d = 0.88
(t, J = 6.2 Hz, 3 H), 1.25 (m, 10 H), 1.44 (s, 9 H), 1.51–1.65
(m, 3 H), 1.82–1.97 (m, 3 H), 3.51 (t, J = 8.6 Hz, 1 H), 3.67
(t, J = 8.4 Hz, 1 H), 3.72–3.89 (m, 1 H), 3.90–4.01 (m, 1 H),
5.12 (br s, 1 H). 13C NMR (75 MHz, CD3Cl): d = 14.1, 22.6,
26.5, 26.8, 28.4 (3 C), 28.9, 29.2, 29.5, 31.8, 35.4, 59.2, 61.1,
68.8, 80.2, 157.4. N-Boc derivatives of (2S,5S)-5-heptyl-2-
hydroxymethyl pyrrolidine: [a]D25 –4.0 (c 0.9, CHCl3).
(20) Penhoat, M.; Levacher, V.; Dupas, G. J. Org. Chem. 2003,
68, 9517.
(21) Lázár, L.; Fülöp, F. Eur. J. Org. Chem. 2003, 3025.
Synlett 2004, No. 11, 2016–2018 © Thieme Stuttgart · New York